Newsroom

The latest news and updates from Oncopeptides

In the spotlight

April 28, 2026
Oncopeptides publishes the 2025 Annual Report
Investor
Regulatory
Read more

Latest press releases

March 16, 2026

Oncopeptides initiates MARINA study to strengthen real-world evidence for Pepaxti in Germany

Science

Latest news

March 24, 2026
Oncopeptalks on real world data and questions from investors

In the latest episode of Oncopeptalks, Sofia Heigis talks more about recent initiatives to strengthen access to real‑world data in the company’s key markets. She also answers a number of questions from investors on everything from the sales landscape in Germany and Italy to the recently completed share issue.

The video is available in Swedish, with Swedish or English subtitles.

Upcoming events

16
Apr
2026
April 16, 2026
EMN 2026
Congress
April 16-
18, 2026
7th European Myeloma Network Meeting
Clarion Congress Hotel, Prague, Czech Republic
14
May
2026
May 14, 2026
COMy
Congress
May 14-
17, 2026
12th World Congress on Controversies in Multiple Myeloma (COMy)
Paris, France & Online
11
Jun
2026
June 11, 2026
EHA Congress 2026
Congress
June 11-
14, 2026
The European Hematology Association (EHA)
Stockholm, Sweden
Select language or region
Region

Learn more about the company Oncopeptides and the work we do to redefine cancer care

Learn more about the company Oncopeptides and the work we do to redefine cancer care

Learn more about the company Oncopeptides and the work we do to redefine cancer care

Learn more about the company Oncopeptides and the work we do to redefine cancer care